Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

VC DEALS ANALYSIS: April sustains bull run of big-buck deals

This article was originally published in Clinica

Executive Summary

The flow of VC deals continued to hold steady in April, with 22 transactions of $1m and over recorded last month and over $626m raised in total.

You may also be interested in...



VC Deals Analysis: Variety In Volume, But Lackluster Value In April

It would have been difficult to beat March's unusual bumper harvest, which benefitted from Grail's near-$1bn round, but venture fundraising efforts in April were stymied by the absence of deals beyond the $50m mark.

VC Deals Analysis: 2016 Bucks The Trend As Investment Dollars Dip

2016 was the year to break the bull run in venture investment activity, with total deal value and volume failing to surpass that of 2015. However, the IVD sector continued to be the most popular area for investment, and technologies that can help unravel the genomic puzzle behind diseases like cancer were the ones that attracted the big bucks last year and look likely to remain so in 2017.

VC Deals Analysis: Where Art Thou, Big Deals?

July's batch of medtech venture financing rounds was a classic example of quantity trumping quality. While deal volume was twice as high as June's, there was a notable absence of meaty transactions.

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT103396

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel